ALDOA and Crohn disease: Here we report that UCB controls glycolysis and downregulates glycolysis-related genes, mainly phosphoglycerate-kinase-1 (PGK1) and aldolase A (ALDOA), these effects being apparent in Th17 cells obtained from healthy individuals but not in those derived from Crohn’s disease patients.